The revenue miss versus consensus is the primary negative, though the 86% YoY growth and improving cash burn trajectory are positive. Watch for the RSNA 2026 CAPTAIN data presentation (Nov 29-Dec 3) and any updates on the Cook Medical distribution ramp and Siemens Healthineers co-marketing progress.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $7.21entry
- T+1 · 8d ago +1.80%α −0.56% · $7.34
- T+5 · 4d ago +2.91%α +0.32% · $7.42
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Profound Medical reported Q3 2026 revenue of $9.8M (+86% YoY), well below the $13.8M consensus, with a GAAP net loss of $0.21 per share versus the $-0.20 consensus estimate. The company guided full-year 2026 revenue to at least $25.0M, announced a Cook Medical distribution agreement, and disclosed a planned CEO succession.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $9.8M, up 86% YoY from $5.3M, but below the $13.8M consensus estimate
- GAAP net loss per share $0.21 vs consensus estimate of $-0.20 (miss)
- Gross margin expanded to 78% from 74% in the prior-year period
- Cash used in operating activities was $5.0M in Q3, down 56% sequentially from $11.3M in Q2
- Full-year 2026 revenue guidance of at least $25.0M; gross margin guidance of 70% or higher
- TULSA-PRO installed base grew to 98 systems; 5,000th procedure performed in October
- Entered into a supply and distribution agreement with Cook Medical for U.S. distribution
- CEO Arun Menawat to transition to Executive Chairman; Richard Fabian to become CEO effective January 14, 2027
- Matthew Sobczyk appointed permanent CFO; Jason Mills joined the Board
- Cash balance of $33.3M at September 30, 2026
Financial Impact
Revenue of $9.8M missed the $13.8M consensus by $4.0M (29% shortfall); EPS of $-0.21 missed the $-0.20 consensus by $0.01
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Recurring - non-capital | $4.1M | +1.0% |
| Capital equipment | $5.7M | +368.0% |
Risk Factors
- Revenue significantly below consensus despite strong YoY growth, indicating Street expectations may have been too high
- Company remains pre-profitable with an accumulated deficit of $312M and operating cash burn of $24.9M year-to-date
- CEO transition introduces execution risk during a critical commercial scaling phase
- Full-year guidance of at least $25.0M implies Q4 revenue of at least $7.35M, which would be a sequential decline from Q3's $9.8M
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-007182 |
| Document: f8k_110526.htm | 0001171843-26-007182 |
| Document: 0001171843-26-007182-index-headers.html | 0001171843-26-007182 |
| Document: 0001171843-26-007182-index.html | 0001171843-26-007182 |
| Document: 0001171843-26-007182.txt | 0001171843-26-007182 |
| 8-K Data (Synthetic) | 0001171843-26-007182 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Viewing Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers